Martina Brueckmann

25PUBLICATIONS
132CO-AUTHORS
PharmacogenomicsPharmaceutical delivery technologiesEpidemiological modellingCardiology (incl. cardiovascular diseases)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|May 31, 2026
Survodutide for the Treatment of Obesity Disease in Japanese Participants: Rationale, Design and Baseline Characteristics of the Phase 3 SYNCHRONIZE-JP Trial.

|Nov 11, 2025
Baseline characteristics in the SYNCHRONIZE™-2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP-1 receptor dual agonist, for obesity in people with type 2 diabetes.

Sean Wharton, Carel W le Roux, Biykem Bozkurt

|Nov 04, 2025
Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double-blind, placebo-controlled, phase 3 trial (SYNCHRONIZE™-1).

Carel W le Roux, Sean Wharton, Biykem Bozkurt

|Nov 04, 2024
Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE™-1 and -2).

Sean Wharton, Carel W le Roux, Mikhail N Kosiborod

|Apr 06, 2024
Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial.

Adrian F Hernandez, Jacob A Udell, W Schuyler Jones

|Feb 13, 2024
Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease.

Manuela Albisetti, Igor Tartakovsky, Jacqueline Halton

Pageof 5

Frequent Collaborators

11 joint publications

Stefan D Anker

11 joint publications

Joo Pedro Ferreira

10 joint publications

Faiez Zannad

10 joint publications

Gerasimos Filippatos